|
1
|
Visser NCM, Reijnen C, Massuger LFAG,
Nagtegaal ID, Bulten J and Pijnenborg JMA: Accuracy of endometrial
sampling in endometrial carcinoma: A Systematic review and
meta-analysis. Obstet Gynecol. 130:803–813. 2017. View Article : Google Scholar
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, ParkinD M, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hinchcliff EM, Bednar EM, Lu KH and
Rauh-Hain JA: Disparities in gynecologic cancer genetics
evaluation. Gynecol Oncol. 153:184–191. 2019. View Article : Google Scholar
|
|
4
|
Schlichter U, Burk O, Worpenberg S and
Klempnauer KH: The chicken Pdcd4 gene is regulated by v-Myb.
Oncogene. 20:231–239. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jansen AP, Camalier CE, Stark C and
Colburn NH: Characterization of programmed cell death 4 in multiple
human cancers reveals a novel enhancer of drug sensitivity. Mol
Cancer Ther. 3:103–110. 2004.PubMed/NCBI
|
|
6
|
Wang Q and Yang HS: The role of Pdcd4 in
tumour suppression and protein translation. Biol Cell. May
28–2018.(Epub ahead of print). View Article : Google Scholar
|
|
7
|
Nieves-Alicea R, Colburn NH, Simeone AM
and Tari AM: Programmed cell death 4 inhibits breast cancer cell
invasion by increasing tissue inhibitor of metalloproteinases-2
expression. Breast Cancer Res Treat. 114:203–209. 2009. View Article : Google Scholar
|
|
8
|
Wei N, Liu SS, Chan KK and Ngan HY: Tumour
suppressive function and modulation of programmed cell death 4
(PDCD4) in ovarian cancer. PLoS One. 7:e303112012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ,
Zhu FL, Wang Q, Gao Q, Ma CH, Sun WS, et al: PDCD4 inhibits the
malignant phenotype of ovarian cancer cells. Cancer Sci.
100:1408–1413. 2009. View Article : Google Scholar
|
|
10
|
Wang X, Wei Z, Gao F, Zhang X, Zhou C, Zhu
F, Wang Q, Gao Q, Ma C, Sun W, et al: Expression and prognostic
significance of PDCD4 in human epithelial ovarian carcinoma. Anti
Res. 28:2991–2996. 2008.
|
|
11
|
Liu Y, Sun H, Mao H, Gao M, Tan X, Li Y,
Li Y, Muloye GM, Zhang L, Wang X and Wei Z: Expression of tumor
suppressor programmed cell death 4 in endometrioid endometrial
carcinomas and clinicopathological significance. Oncol Lett.
15:9369–9376. 2018.
|
|
12
|
Zhang X, Wang X, Song X, Liu C, Shi Y,
Wang Y, Afonja O, Ma C, Chen YH and Zhang L: Programmed cell death
4 enhances chemosensitivity of ovarian cancer cells by activating
death receptor pathway in vitro and in vivo. Cancer Sci.
101:2163–2170. 2010. View Article : Google Scholar
|
|
13
|
Gao F, Wang X, Zhu F, Wang Q, Zhang X, Guo
C, Zhou C, Ma C, Sun W, Zhang Y, et al: PDCD4 gene silencing in
gliomas is associated with 5′CpG island methylation and
unfavourable prognosis. J Cell Mol Med. 13:4257–4267. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun J, Yong J and Zhang H: microRNA-93,
upregulated in serum of nasopharyngeal carcinoma patients, promotes
tumor cell proliferation by targeting PDCD4. Exp Ther Med.
19:2579–2587. 2020.PubMed/NCBI
|
|
15
|
Zhou XH, Chai HX, Bai M and Zhang Z:
LncRNA-GAS5 regulates PDCD4 expression and mediates myocardial
infarction-induced cardiomyocytes apoptosis via targeting MiR-21.
Cell Cycle. 19:1363–1377. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui H, Wang Q, Lei Z, Feng M, Zhao Z, Wang
Y and Wei G: DTL promotes cancer progression by PDCD4
ubiquitin-dependent degradation. J Exp Clin Cancer Res. 38:3502019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Townson SM, Kang K, Lee AV and Oesterreich
S: Novel role of the RET finger protein in estrogen
receptor-mediated transcription in MCF-7 cells. Biochem Biophys Res
Commun. 349:540–548. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Micale L, Chaignat E, Fusco C, Reymond A
and Merla G: The tripartite motif: Structure and function. Adv Exp
Med Biol. 770:11–25. 2012. View Article : Google Scholar
|
|
19
|
Joazeiro CA and Weissman AM: RING finger
proteins: Mediators of ubiquitin ligase activity. Cell.
102:549–552. 2000. View Article : Google Scholar
|
|
20
|
Harbers M, Nomura T, Ohno S and Ishii S:
Intracellular localization of the Ret finger protein depends on a
functional nuclear export signal and protein kinase C activation. J
Biol Chem. 276:48596–48607. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iwakoshi A, Murakumo Y, Kato T, Kitamura
A, Mii S, Saito S, Yatabe Y and Takahashi M: RET finger protein
expression is associated with prognosis in lung cancer with
epidermal growth factor receptor mutations. Pathol Int. 62:324–330.
2012. View Article : Google Scholar
|
|
22
|
Tezel GG, Uner A, Yildiz I, Guler G and
Takahashi M: RET finger protein expression in invasive breast
carcinoma: Relationship between RFP and ErbB2 expression. Pathol
Res Pract. 205:403–408. 2009. View Article : Google Scholar
|
|
23
|
Ma Y, Wei Z, Bast RC Jr, Wang Z, Li Y, Gao
M, Liu Y and Wang X, Guo C, Zhang L and Wang X: Downregulation of
TRIM27 expression inhibits the proliferation of ovarian cancer
cells in vitro and in vivo. Lab Invest. 96:37–48. 2016. View Article : Google Scholar
|
|
24
|
Tsukamoto H, Kato T, Enomoto A, Nakamura
N, Shimono Y, Jijiwa M, Asai N, Murakumo Y, Shibata K, Kikkawa F
and Takahashi M: Expression of Ret finger protein correlates with
outcomes in endometrial cancer. Cancer Sci. 100:1895–1901. 2009.
View Article : Google Scholar
|
|
25
|
Horio M, Kato T, Mii S, Enomoto A, Asai M,
Asai N, Murakumo Y, Shibata K, Kikkawa F and Takahashi M:
Expression of RET finger protein predicts chemoresistance in
epithelial ovarian cancer. Cancer Med. 1:218–229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai X, Srivastava S, Sun Y, Li Z, Wu H,
Zuvela-Jelaska L, Li J, Salamon RS, Backer JM and Skolnik EY:
Tripartite motif containing protein 27 negatively regulates CD4 T
cells by ubiquitinating and inhibiting the class II PI3K-C2β. Proc
Natl Acad Sci USA. 108:20072–20077. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng Q, Hou J, Zhou Y, Yang Y, Xie B and
Cao X: Siglec1 suppresses antiviral innate immune response by
inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell
Res. 25:1121–1136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Böhm M Sawicka K, Siebrasse JP,
Brehmer-Fastnacht A, Peters R and Klempnauer KH: The transformation
suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and
binds RNA. Oncogene. 22:4905–4910. 2003. View Article : Google Scholar
|
|
30
|
Matsuhashi S, Manirujjaman M, Hamajima H
and Ozaki I: Control mechanisms of the tumor suppressor PDCD4:
Expression and functions. Int J Mol Sci. 20:23042019. View Article : Google Scholar
|
|
31
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dorrello NV, Peschiaroli A, Guardavaccaro
D, Colburn NH, Sherman NE and Pagano M: S6K1- and betaTRCP-mediated
degradation of PDCD4 promotes protein translation and cell growth.
Science. 314:467–4671. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mallette FA and Richard S: K48-linked
ubiquitination and protein degradation regulate 53BP1 recruitment
at DNA damage sites. Cell Res. 22:1221–1223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Metcalf JL, Bradshaw PS, Komosa M, Greer
SN, Stephen Meyn M and Ohh M: K63-Ubiquitylation of VHL by SOCS1
mediates DNA double-strand break repair. Oncogene. 33:1055–1065.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Joung H, Eom GH, Choe N, Lee HM, Ko JH,
Kwon DH, Nam YS, Min H, Shin S, Kook J, et al: Ret finger protein
mediates Pax7-induced ubiquitination of MyoD in skeletal muscle
atrophy. Cell Signal. 26:2240–2248. 2014. View Article : Google Scholar
|
|
36
|
Zurek B, Schoultz I, Neerincx A,
Napolitano LM, Birkner K, Bennek E, Sellge G, Lerm M, Meroni G,
Söderholm JD and Kufer TA: TRIM27 negatively regulates NOD2 by
ubiquitination and proteasomal degradation. PLoS One. 7:e412552012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hao YH, Doyle JM, Ramanathan S, Gomez TS,
Jia D, Xu M, Chen ZJ, Billadeau DD, Rosen MK and Potts PR:
Regulation of WASH-dependent actin polymerization and protein
trafficking by ubiquitination. Cell. 152:1051–1064. 2013.
View Article : Google Scholar
|
|
38
|
Lipkowitz S and Weissman AM: RINGs of good
and evil: RING finger ubiquitin ligases at the crossroads of tumour
suppression and oncogenesis. Nat Rev Cancer. 11:629–643. 2011.
View Article : Google Scholar : PubMed/NCBI
|
